We are trying to help provide evidence-based recommendations for patients who want to manage their obesity and then help them to access care and be persistent with it. Advertisement Advertisement Procedure offers potential for less pain and faster recovery in selected patients Challenges include multimorbidity, polypharmacy, limited mobility and sarcopenia Pheochromocytoma case underscores the value in considering atypical presentations Advocacy group underscores need for multidisciplinary expertise A reconcilable divorce A review of the latest evidence about purported side effects High-volume surgery center can make a difference Advancements in equipment and technology drive the use of HCL therapy for pregnant women with T1D
Retatrutide is an unlicensed investigational tri-agonist targeting GLP-1, GIP, and glucagon receptors
Water retention patterns, appetite changes, and metabolic rate fluctuations tied to the menstrual cycle can create a less smooth weight loss curve
Angstwurm MW et al (2007) Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock
The Ripple Effect of the Ozempic Storm When a major part of society is already under the influence of weight loss, we will start to see changes in behaviour and spending shifts
